Canakinumab in Patients With COVID-19 and Type 2 Diabetes
Clinical trial NCT04510493 · COMPLETED
Trial details
- NCT number
- NCT04510493
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2021-08-17
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.